Allergies News and Research

Latest Allergies News and Research

Recommendations to help manage five common holiday-related stressors

Although the holiday season can be a time for joy, fun, and family, it is also common for people to feel overwhelmed or experience temporary anxiety, stress, or sadness.

19 Nov 2019

New drug combo may improve pancreatic cancer therapy

A new study by scientists at Sanford Burnham Prebys Medical Discovery Institute have discovered a combination of two cancer-fighting drugs that successfully worked on pancreatic tumor in mice, shrinking them significantly, and paving the way for a speedy clinical trial designed to test their efficacy in humans.

18 Nov 2019

Study investigates health, well-being of adults who were born preterm at very low birth weight

The Finnish Institute for Health and Welfare is investigating the health and well-being of adults who were born preterm at very low birth weight in a series of studies that are unique worldwide.

18 Nov 2019

Tailored T-cells safe, may be effective in preventing and treating multiple viral infections

Tailored T-cells specially designed to combat a half dozen viruses are safe and may be effective in preventing and treating multiple viral infections, according to research led by Children's National Hospital faculty.

18 Nov 2019

New NIH funding will accelerate progress in TB vaccine development

Seattle Children's Research Institute is one of three recipients of $30 million in first-year-funding provided by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to establish centers for immunology research to accelerate progress in tuberculosis vaccine development.

15 Nov 2019

CSU awarded $1.2 million subcontract to accelerate tuberculosis vaccine development

A team of researchers in the Department of Microbiology, Immunology and Pathology at Colorado State University aim to advance what is known about the complex immune response necessary to prevent tuberculosis disease.

15 Nov 2019

New treatment stops peanut allergy for 6 weeks with single dose

A small study published in the journal JCI Insight on November 14, 2019, suggests that antibody treatment could help people with severe allergy to peanuts eat a small amount of peanut-containing food just two weeks later, without any ill effects. This seems to show that this is a safe, fast and effective treatment for food allergy.

14 Nov 2019

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

The National Institute of Allergy and Infectious Diseases has awarded Integral Molecular a contract (75N93019C00073) which will provide up to $5.5M over the next five years to define antibody responses to pathogenic viruses including Zika, Marburg and equine encephalitis viruses, aiding the discovery of vaccines and therapeutics against these currently untreatable and often lethal viruses.

14 Nov 2019

UAB study suggests potential treatment target for IPF

Long-held dogma says lung fibrosis in diseases like idiopathic pulmonary fibrosis, or IPF, results from recurrent injury to alveolar epithelium that is followed by dysregulated repair.

12 Nov 2019

Lung inflammation in a case of a 16-year-old linked to vaping

The Centre for Disease Control and Prevention (CDC) has warned earlier last month about the possible risk of lung inflammation from the exposure to the fluid in e-cigarettes. Now a case of a 16-year-old boy was reported with life threatening lung inflammation leading to respiratory failure.

12 Nov 2019

CRIPSR could be used to detect disease

CRISPR could be used to establish new diagnostic blood tests by identifying viral nucleic acids, such as Parvo or HPV.

11 Nov 2019

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

Scientists funded by the National Institutes of Health have developed an investigational vaccine that protected cynomolgus macaques against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa.

8 Nov 2019

New information on benefits of oral food challenges when diagnosing food allergies

Oral food challenges (OFCs) are the gold standard for allergists when diagnosing a food allergy. The person being tested is given a very small dose of the food by mouth under the supervision of a board-certified allergist to test for a severe reaction.

8 Nov 2019

Three studies present new information on penicillin allergy

At some point you may have had a reaction to penicillin and were told you were allergic. And there's a good chance it has stayed in your chart throughout your childhood and into adulthood.

8 Nov 2019

Study: Parents of pediatric patients equally satisfied with in-person appointments and telemedicine

Telemedicine visits may still seem like a futuristic idea for many. But a new study being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Houston showed most parents of pediatric patients were more or equally satisfied with the treatment their children received during telemedicine visits for allergies and asthma.

8 Nov 2019

Allergy shots effective in reducing PFAS symptoms in pediatric patients

We know that children with pollen food allergy syndrome (PFAS) also suffer from seasonal allergies.

8 Nov 2019

Online information on food allergies has negative impact on medical decisions

The social media stream on food allergies is never-ending. Your Facebook and Twitter friends seem to know what they're talking about. And why shouldn't you believe all those news articles – even if you've never heard of some of the sources?

8 Nov 2019

Study shows link between family history of cancer and childhood asthma diagnosis

It's well known there's a genetic component to cancer, and that cancer often runs in families. A new study being presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting in Houston shows an association between a family history of cancer and a childhood asthma diagnosis.

8 Nov 2019

New strain of HIV discovered and sequenced

Researchers have for the first time in twenty years come upon a new strain of HIV or Human Immunodeficiency Virus. This strain is a part of the Group M type of HIV-1. HIV-1 is the causative agent of worldwide HIV infections.

7 Nov 2019

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

The Human Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

5 Nov 2019

Allergies News and Research

Latest Allergies News and Research

Recommendations to help manage five common holiday-related stressors

New drug combo may improve pancreatic cancer therapy

Study investigates health, well-being of adults who were born preterm at very low birth weight

Tailored T-cells safe, may be effective in preventing and treating multiple viral infections

New NIH funding will accelerate progress in TB vaccine development

CSU awarded $1.2 million subcontract to accelerate tuberculosis vaccine development

New treatment stops peanut allergy for 6 weeks with single dose

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

UAB study suggests potential treatment target for IPF

Lung inflammation in a case of a 16-year-old linked to vaping

CRIPSR could be used to detect disease

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

New information on benefits of oral food challenges when diagnosing food allergies

Three studies present new information on penicillin allergy

Study: Parents of pediatric patients equally satisfied with in-person appointments and telemedicine

Allergy shots effective in reducing PFAS symptoms in pediatric patients

Online information on food allergies has negative impact on medical decisions

Study shows link between family history of cancer and childhood asthma diagnosis

New strain of HIV discovered and sequenced

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Allergies News and Research

Latest Allergies News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in